[1] 蔡宝祥. 家畜传染病学[M]. 北京:中国农业出版社, 2001.
[2] PALYA V, KISS I, TATÁR-KIS T, et al. Advancement in vaccination against Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions[J]. Avian Diseases , 2017, 56(2):282-287.
[3] 罗玉均,陈建红,张济培. 鸡新城疫的诊断与防制[J]. 养禽与禽病防治, 2004 (12):7.
LUO Y J, CHEN J H, ZHANG J P. Diagnosis and control of Newcastle disease[J]. Poultry Husbandry and Disease Control , 2004 (12):7.(in Chinese)
[4] ZHANG Y Q, SUN Z A, LIU J G, et al. Flavone ingredients can synergistically inhibit NDV infecting cell and improve ND vaccine's protective rate[J]. International Journal of Biological Macromolecules , 2012, 51(3):201-208.
[5] CHEN Y, ZHU J. Anti-HBV effect of individual traditional Chinese herbal medicine in vitro and in vivo : an analytic review[J]. Journal of Viral Hepatitis , 2013, 20(7):445-452.
[6] GUO M, ZHANG N, LI D, et al. Baicalin plays an anti-inflammatory role through reducing nuclear factor-κB and p38 phosphorylation in S. aureus -induced mastitis[J]. International Immunopharmacology , 2013, 16(2):125-130.
[7] NAYAK M K, AGRAWAL A S, BOSE S, et al. Antiviral activity of baicalin against influenza virus H1N1-pdm09 is due to modulation of NS1-mediated cellular innate immune responses[J]. Journal of Antimicrobial Chemotherapy , 2014, 69(5):1298-1310.
[8] ZHU J L, WANG J F, SHENG Y, et al. Baicalin improves survival in a murine model of polymicrobial sepsis via suppressing inflammatory response and lymphocyte apoptosis[J]. PLoS One , 2012, 7(5):e35523.
[9] 刘晓婷. 黄芩苷对流感病毒H1N1感染A549细胞的作用及免疫调控机制的研究[D]. 北京:北京中医药大学, 2016.
LIU X T. Effect of Baicalin on influenza virus H1N1 infection in A549 cells and its immunoregulation mechanism[D]. Beijing: Beijing University of Chinese Medicine, 2016.(in Chinese with English abstract)
[10] JIA Y, XU R G, HU Y C, et al. Anti-NDV activity of baicalin from a traditional Chinese medicine in vitro [J]. Journal of Veterinary Medical Science , 2016, 78(5):819-824.
[11] KUMAR H, KAWAI T, AKIRA S. Biochemical and biophysical research communications toll-like receptors and innate immunity[J]. Biochemical and Biophysical Research Communications , 2009, 388(4):621-625.
[12] 何晓霞, 白海. Toll样受体的研究进展[J]. 西北国防医学杂志,2010,31(6):445-446.
HE X X, BAI H. Advances in toll like receptors[J]. Medical Journal of National Defending Forces in Northwest China , 2010,31(6):445-446.(in Chinese)
[13] 丁娜, 孙英杰, 丁铲. 禽Toll样受体研究进展[J]. 中国动物传染病学报,2011,19(6):77-83.
DING N, SUN Y J, DING C. Research progress in avian toll-like receotors[J]. Chinese Journal of Veterinary Parasitology , 2011, 19(6):77-83.(in Chinese with English abstract)
[14] VERMA A, PRASAD K N, SINGH A K, et al. Evaluation of the MTT lymphocyte proliferation assay for the diagnosis of neurocysticercosis[J]. Journal of Microbiological Methods , 2010, 81(2):175-178.
[15] CHEN M Z, XIE H G, YANG L W, et al. In vitro anti-influenza virus activities of sulfated polysaccharide fractions from Gracilaria lemaneiformis [J]. Virologica Sinica , 2010, 25(5):341-351.
[16] 张婷婷. 两种不同来源新城疫病毒的感染对鸡免疫作用的分子机制[D]. 哈尔滨:东北农业大学, 2015.
ZHANG T T. The molecular mechanism of infection of Newcastle Disease Virus from different hosts on theimmune function of chickens[D]. Harbin: Northeast Agricultural University, 2015.(in Chinese with English abstract)
[17] AKIRA S, UEMATSU S, TAKEUCHI O. Pathogen recognition and innate immunity[J]. Cell , 2006, 124(4):783-801.
[18] KURTJONES E A, BELKO J, YU C, et al. The role of toll-like receptors in herpes simplex infection in neonates[J]. Journal of Infectious Diseases , 2005, 191(5):746-748.
[19] ZHOU S, HALLE A, KURTJONES E A, et al. Lymphocytic choriomeningitis virus (LCMV) infection of CNS glial cells results in TLR2-MyD88/Mal-dependent inflammatory responses[J]. Journal of Neuroimmunology , 2008, 194(1/2):70.
[20] SEGOVIA J, SABBAH A, MGBMENA V, et al. TLR2/MyD88/NF-κB pathway, reactive oxygen species, potassium efflux activates NLRP3/ASC inflammasome during respiratory syncytial virus infection[J]. PLoS One , 2012, 7(1):e29695.
[21] PAULINE MENAGER P R F M. Toll-like receptor 3 (TLR3) plays a major role in the formation of rabies virus Negri Bodies[J]. PLoS Pathogens , 2009, 5(2):e1000315.
[22] ALEXOPOULOU L, HOLT A C, MEDZHITOV R, et al. Recognition of double-stranded RNA and activation of NF-kappaB by toll-like receptor 3[J]. Nature , 2001, 413(6857):732-738.
[23] CHENG J, SUN Y, ZHANG X, et al. Toll-like receptor 3 inhibits Newcastle disease virus replication through activation of pro-inflammatory cytokines and the type-1 interferon pathway[J]. Archives of Virology , 2014, 159(11):2937-2948.
[24] TAKEUCHI O, AKIRA S. MyD88 as a bottle neck in Toll/IL-1 signaling[J]. Current Topics in Microbiology & Immunology , 2002, 270:155-167.
[25] YAMAMOTO M, SATO S, HEMMI H, et al. TRAM is specifically involved in the toll-like receptor 4-mediated MyD88-independent signaling pathway[J]. Nature Immunology , 2003, 4(11):1144-1150.
[26] TOWN T, BAI F W, WANG T, et al. Toll-like receptor 7 mitigates lethal West Nile encephalitis via interleukin 23-dependent immune cell infiltration and homing[J]. Immunity , 2009, 30(2):242-253.
[27] BAKER D G, WOODS T A, BUTCHI N B, et al. Toll-like receptor 7 suppresses virus replication in neurons but does not affect viral pathogenesis in a mouse model of Langat virus infection[J]. Journal of General Virology , 2013,94(Pt 2):336-347.
[28] KLEIN K P, TAN L, WERKMAN W, et al. The role of toll-like receptors in regulating the immune response against respiratory syncytial virus[J]. Critical Reviews in Immunology , 2009, 29(6):531-550. |